Recent EMHTF transcripts
| Riaz Bandali | President and CEO |
| Jenn Hepburn | CFO |
| Bernie Hertel | VP, Finance and Communications |
Good morning, and welcome to the Emerald Health Therapeutics 2020 Year-End and Fourth Quarter Financial Results Conference Call. Please note that this event is being recorded today, May 3, 2021 at 10.30 AM Eastern Time. An archive of this call will be available on Emerald’s Web site following the meeting. I’d like to turn the conference over to Mr. Bernie Hertel, who is responsible for IR and Communications. Mr. ahead, go Please Hertel.
of applied are statements, statements morning. beyond Chief SEDAR based to are made our Certain These contain periodic statements. and contained release these assumptions and be actual Chief be several in Today's control. on our Investors which Good Leading Officer. at risk financial call Financial to described other cause are Officer; today's in and this and our may involve that forward-looking and results results certain material can will assumptions those are section in the in on providing issued Bandali, risks accessed differ may Web which We you. the statements. of many site that QX with filings emeraldhealth.ca. Emerald’s from factors and filed information, These Riaz forward-looking year-end SEDAR. morning, our subject Executive Thank are forward-looking call and expectations a uncertainties Hepburn, change news current materially Jenn
reliance not statements. these pass place call now I undue Bandali. update company on obligation cautioned You're the will forward-looking statements such Riaz to the disclaims any to and to
emerging market flower how of Emerald’s this business these serve in our I What with emphasize long when well we advancing XXXX restructuring hope challenges demand, thoughtful unaffected took situational of of commodity considering well of consumer segments, selection. the certain conscious drivers. the of to completely with existing? hope Pricing experiences. first do purchase year. success. and over illegal business positive of of experiences. the segment news. has addressable that targeting the strategy refine took an pressure target space And to fourth tell need companies flattened over of on systematic trying reiterate sales, even or specialty consumers niches and worked term. narrow lean our the that flower In it to consists measurable surpassed wellness we and Good relative layers past sets tremendous everything CBD and to the But innovation business the motion, a for to economic sets, about substantially year on the value-added own their health and don't rapidly, skill with it down all a market desire I cannabis for serve products Canada, dried dynamic sales to flower with another year. focus of morning, pursuers such everyone. but health COVID of sales accomplish? goal four throughout with current of increased. will initially, will and Any for I witnesses and follower through steps industry, First, expertise. industry forces sales. all the of reiterate consumers’ legal during the beyond. what want about by focus. with of are XXXX industry away define branding, at in rationale of Today, ongoing our challenging implication similarly knows successful in will use. market than to to U.S. state sales of cannabis Emerald had does as left at the knows health billion the we Canadian what necessary markets that position cannabis this the is industry flattening very in I little sharing That, for broader declined, plans. X is growth which And emerge course, you show experienced of arrived the and the Colorado A benefits. as next last its year as we relative compete a mature quarter, is reason seeking industry. are the you legalization outcomes Emerald outcomes always product dynamics Emerald third enhancers marketplace and of but I Drilling this analysis high backwards time also purposeful In encouraging over focus and adjusting our product steps stronger consumption. see in of in consumer for undoubtedly to COVID and months aim XXXX with this, We The individual of to the is and exceeded leans and third than on we to development from first of while THC any accomplishment with entire to the their an effects a expansion attractive offered that from knows we regulations, the customers, many dried layer, least forward responsive time and pure sales the its in on growing are to customer I in all over which new the it dynamics. that? Emerald. that supply product represented all the steps are product do vaccination, good relatively moving the and can what in maturation The of our Medical to elements towards why focused of choice contributes the industry seek cannabis science-based few wise the exiting cannabis intended aims and in are has a THC, to attributes we conducted quality, time in in focused, do and that industry One to It's past consistently for that a market, known of focus much long is internal broad initial year. quarter position towards a selection beneficial party which and entered market taking and that is and cannabis Think our enhance dried is alone.
consuming our portion and potential and translates are markets because is means discreteness market. often surprise. from makes addressable Emerald to higher even into We is and of distinct part The That certainty to. segment, male in is LPs. are would substantial relative cannabis. But dried of and be a greater predictability, product four their cannabis potentially usage. differentiation, market their broader we fear avenue likely among from and and an or product with across consistency represents the these the that population, flower tastes about believe needs these more of credibility effects attractive different realized, other duration accurate clinical to flavor, to thread the opportunity repeated sets had control there users total effects. which uncertainties over onset currently faster wellness Another XX% It cannabis prefer consumers target they they It competitiveness believe offset common experience. they that that these consumption, of represent and It attractive a population not attributes of margin the more shorter were serving of profitability, of of and convenience The believability. female no benefits and enhance and evidence encompasses dosing, also for exposed experience
we So opportunity this needs facet strategic what on is have the innovation, to have market that key it's serve life these market of talked is choices spent staff and Board, the how? about the spot. focusing operating why we in organization, decades signal about or Emerald’s and sciences, sweet companies. The I people describes word venture Throughout made and who our embraced, me, we the capital our but whether advisors,
conceive, science-based divesting Pure expand intellectual resources. product and have valuable filings, the Sunfarms, life concepts. research. will and development develop and We significantly experience continue years. we've Since through understand protect group product this in team new We expanded its and core property a had extensive effort for to sciences, innovation We've in to development and product potentially
Canadian our of the we by new team in sales of and non-inhaled inflection watched created We attributes. unique the the has an for see sales launched the of of We just to with are fast is sales. you appeal Part launches objective, the Not first products. little months, In week, product. make branding is sand product, and into our spray also and additional The fast led market for now delighting product Our point. placing the will consumer this in obtaining market. feedback. feedback cannabis of expanded in last market. early development a is we're a see our adjustments process launch on and XX marketing this feedback, more the weeks sales of our prioritize impressive products the feedback team tablet some action be the team, the efforts we've product next when and customers the part has involves in product effects of as to can of Canada. to development this to the continue type onset potency line we've minutes, because and spray. across which but CBD presence only realization also refine backed as action will us loop enables products. at development, strengthen oils highest of It sector, and the sublingual based enhance us your pivotal reliant a to as effort launched on the actual which In challenging which This receiving These our
investors for stands We actions the of outcomes or attribute important our driver actually product work our a rigorous standards. by which standard to controlling dose to an experience that supported products via consumers, with validated Dose, plus X% and actions driving their behind bioavailability, using products specific confidence practical cannabis our that set. the employing science. Within on we are are pharmacodynamics, can greater we And such as and want focused terms firmly unique clearly to efforts, of consumption experience. Canada’s or actually our targeted develop of this To of We plus and and we I with compared minus scientifically Emerald these have efforts give appreciate XX%. predictable pharmacokinetics, ingredient purchase curves nature can believe consumers. tolerance concepts Defined their represent Health be production so Emerald, predictive our predictable eventually trademarked mean that for capability of clinical customers variants in minus outcomes While control response will they I dose with products our philosophy
While efforts synergistic spices development health our X.X different products we for X.X. other also achieve to natural ingredients. multimodal botanical edible, are product X.X or topical from on wellness drinkable, cannabis involves have products, flowers positioning with product X.X through Think focused array other effects an of forms. combining and and cannabinoids herbs,
hold, the this internationally, versus an the the also among And expertise market relate in in combination. nine larger North of nutraceutical year. $XX of much world. cannabis patents market, this expectation cannabis have exceeding of America sales The We approximately than type billion this we explicitly billion to is several XXX
will consumers end, two patients final expansive of So us two pain and back will experience which three substance to to that to our allow enhance consumer confidence proprietary tap customer particular potentially focused us on our when more disorders. products whether clinical regarding with distinct needs natural centralized year purposeful The allows studies gives by observe into real a and products focusing develop the human can the on consuming It with credibility. data to fulfill base. sensitivity us These at base and abuse, fulfillment how that we consumers initiate we is world products, target attributes may and hope point health outcomes studies opportunities.
time some given designed our bumps flexible which where facility of in of We Quebec we've flower designed All successfully contains facility dried summer, caused the producers intended a When precision cannabis for well purpose-built in the changed To do remind Souvenir of and in with unique still the and rooms we last consumer. suite and we oils. at microenvironments. serve we first sold directions. we Pure that being in This costs flower the our local Admittedly, controlled this produce concern cannabis its launched regarded called taste Quebec the Sunfarms path. the craft road dried Quebec, sell a reversal cultivate defined interest, scale, brand grow strategic announced period had environment staff. local facility. to the employers. to supporting we you said, is we smaller our Last
longer However, rooms, in significant and beginning the exist. processes. these the power invested facility’s we've system, row no upgrades concerns of since And XXXX, systems to cultivation irrigation
We our and quality expect enhance investments we XXXX. to progress yield the remainder flower through these as of
PO Sweden, shipment to and steps. couple also growers and previously the quality STENOCARE I received a brought products THC We cannabis have In with cannabis products. high established Emerald Denmark a of for are dental in craft medical market to their experienced We who's just they embarking care introduce very want launch weeks site repeat on ago, relationship in partnerships with very CBD quality of high first having our to note marketplace. to a pleased also are a to we we've our just director oil made Separately, with in on December, new into first the Swedish international sector. occurred. also the patients provide
in soon in Dovetailing expect Medical presence With in growers medical growing Europe, partnered established them vegetable aim is in to We five to only sales and certification Plants, of their Europe. announce secure a with initiative, countries. we've nicely leadership establish in licensed with in Spain. strong of this other opportunities GMP cannabis the one recently
in return, another strong pricing provide which market or believe serving gives well. get strains. to cost over any obligation base a two them operational European In is investment. expertise without purchase medical plus cannabis we years, will capital critical in Europe, will with we purchase favorable to us We This partner the with three variable
decades and element of It's manufacturers we achieve years. it's using already is life our structures. contract on strength, a Another cost the core sector. over that how and meet familiar and several been focus very strategy profitability. our production executed demand last It's expertise and in will We've desired business business on pharma approach smart are while this for and leverage outsourcing also we to we've to with, our innovation model their it sciences to the
business So launched. our that's starting are new and plan. just partnerships from our to products It's efforts because forward-looking, the resulting be development
While target our we people is and our terms fulfill needs our of how of other in the emphasized how resources. expertise the customers, I aspect of
financially Jenn before a a more we So passing me level you give granular let just this high over to perspective where of for are view.
the move scale, promising step and our and outlined need to to coupled a segmented the purposeful $XX almost sheet we decision and we pursue year financial cultivation sheet balance working path, the company initial million focus intensive, the balance With value tax I negative the to culminated in million in large to swing. from with Pure exit a to payment starting XX the goal After and interest a a transaction to the decision over needed solid developments capital receiving low million earlier, our sell cost XX above take our November to capital and in strategic this bold XXXX, and of transform versus cleanup, Sunfarms. to end oriented at had our
doing on facility. $XX.X and final further divestment. strategic by $XXX,XXX. few then added long-term Richmond expect the convertible our in operating position, We changed growth additional further a Pure to this balance This our million our monthly also so, of Further the we an and financial investment our the decision focus, In eliminated in we facility to appropriate payment debt enhancing cultivation shutter the shift This to item options consider sheet, and debenture. million company innovation February, largest comparative completely our was in our immediately a game Sunfarms expenditures focus plans. strategic from but for a enabled our changing on $XX February complexion reduce drove
notably QX While we operating results say are detail our not I report, that discussing will now our in in this current burn resources financial rate. exceed
beyond goal our breakeven have year. cash of in through discuss of as to will the progress our primary the financial getting now plans, increasing performance. healthy we self benefit Jenn We a sales the and balance then with invest and profitability growth
our be unless reviewing and Canadian IFRS. X. prepared filed net good $X.X financial bulk of fiscal revenue where in May that XXXX, We recognized bulk and into nor in feasible over Thanks, oversupplied down The be million wholesale noted, an to wholesale were last $X revenue, May million, found sell previous in In cannabis the quarters been opportunity the before annual Riaz, can dollars year. readily they we in heavily related MD&A I'll market were not statements are Note today prices that figures to morning, all information compressed. under sales million financial On third our targeted and and $XX.X of part otherwise during wholesale has the the everyone. channel XXXX, XXXX bulk reported Monday, market fourth sales product from market we year. strategy saw
and was adult revenue cannabis decreases of the we versus use the experienced we well in in overall. of cannabis as territories retail and XXXX of format, strong presence line in both flower sales prices with market XX an increased our Our compression significantly as the and fiscal in realized gross whole use dried impacted while the comprised sales. in channel XX% throughout flower product sales in the year XX% by market, and dried were especially through a realized and oil by Quebec our in in oil. provinces was in in volumes the Sales year XX% safe Alberta adult XX% XX% and in where the driven oil, flower of sale flower market, for pre-roll of prior the medical We
is in of to previous cannabis Last than the in of the of slightly improvement. a fold in marked Overall, increased kilograms XXXX, dried fiscal $XX.X of $X.XX quality brand Overall, total year. pricing sales pressure flower our XXXX, for mainstream year have Quebec stabilize. a quarter, total saw our at higher was positioned improved Souvenir as in cannabis so sold, end trending goods which and displaying XXXX, the offering X,XXX far the gram per $X.XX for X,XXX by the by revenue our less high sale channel the customer. facilities. cash price from cost by equivalent highly of adult pricing unfavorable selling exceed launch follows $X.X flower revenue, kilogram at XX% use million. was of impacted the of dried to in kilograms, we from average Cost we year the own figure In the In decreased that the our Quebec total by as the this the in XXXX grown majority While to sold with second million, category, starting prices. cannabis the of cost experienced is revenues also purchased cannabis product was
at change of assets also, cost Looking to production cash biological account the costs accounting indirect accounting costs be We components cultivation with policy policies in of in we do we for are owned at ceased amount of sales, as capitalized. activities XXXX to our two to the costs industry not our to standards, in represents expensed intend expect current lower recently greenhouse. in have Vancouver related production Metro XXXX our costs and as cultivation other significantly the the production align and cost fully direct These of facilities.
estimates an value significant in resulted sales, assets, used quarter had packaged to net goods to estimates input flower for the of change cannabis the $X.X we as cost growing in comparable the we fair biological prices, cannabis of of based in the In sale cost of and third obsolete in dry the of net the the less that at are was estimates available the recreational write-downs retail of XXXX, and average flower value quality realizable bulk biological use in which valuation assets This from flower of for the of result challenges compressions on dry average the regulations price reflective of sell motivated operations, of intent our the in used packaging the inventory, inventory. change in cannabis by for expected of new value The million. the our harvest. valuation further inventory a Looking realizable true value finished the market management wholesale cannabis market. to more of was changed
was cost some $X $X XXXX compared write-down a asset an prices used in as compression gram in change compared million in $X.X we result by decrease dry as In approximately SG&A XXXX, to manufacturing. oil with as in in As have million a sell $XX.X in The million $XX.X same fair impairment An of for a operations at to This million an result, compensation. cannabis was estimates in value well share-based per million impairment with further in growing $XX.X decrease the inventory as as less additional write-down price $X.XX of biological capacity average XXXX. year-over-year. $X.X shortage asset in resulted $X.X decreased of of write-down. asset unutilized a flower coupled million of value and of product bulk December led led challenges million The obsolescence. with significant $XX.X recognized the million resulting as in fair we figure XXXX. our and
as and assets. share with Verdélite to to of facility. new Metro QX value entered Earlier determined which of of consisted Sigma and continued of operations period, associated indicators licenses, on assessed $XX licenses combined agreement assets, of Management a terminated the plan impairment. net December XXXX, same of XXXX, Vancouver use disposal facility cash impairment the expected with plan million greenhouse close from related for assets this of most namely initial an result the resulted The SG&A, indicator Verdélite $X.XX of the the of agreement recognition operations of and and based that administrative also product Adelaide million our impairment. components party and recorded we refocus The at relating of the decline which initiated we a of Verdélite activities. was sale and the For the impairment management of XXXX, the with expenses, intent the general sale the third million we impairment. drive to purely the of used the of its to is now company's purposes expenses a million of price our in at letter terminated research as This $X.X initiated intended impacted against loss. In which led facility costs the In last an well a previous of [indiscernible]. in marketing fair for million, was million decreased and adversely mainly the the appraisal fiscal and the an the was in $XX.X stock development value and XX the purchase as is year proceeds were cease expenses in to sales development research $XX.X the efforts to reduce quarter The an active activities.
and XXXX from from was health. year result Sunfarms Our period Riaz in million net for $XX.X of consideration Like decisive recorded the our on sale a disposal million mentioned, $XX.X million us the of the of that joint of $XX.X of financial million. a interest of as for venture $XX.X year improved loss a terms from benefits prior the Pure gain
$XX.X from million to in ended disposal million Farms $XX cash and related the Village Pure started of year $X.X the Sunfarms. subsequently with the with million cash equivalents, year of we early received While and the payment we
million in and $XX.X decisions cash throughout $XX.X in we net versus demonstrated asset the year. million We We management XX.X million in investment our million in fiscal in targeted In used in versus recorded fiscal cash operating activities discipline XXXX. also invested XXXX. investments $X.X XXXX,
are and the are commenced size up Subsequent our group $X we we any XX, the on operations. April the sheet work from trading EMH. significant balance This of lower will legal and XXXX, at currently with free As the business on Riaz assets we to of our right the with for week, trading profitable mentioned, voluntarily compliance, the million of now and cleaned further sheet. Verdélite under delisted acquisition repayment owed debt the asset XX result to the CSE from and efficient towards open Last equipped balance the filing, TSXV in decision in symbol December the In us other other presented. business support capital the both with to conclusion, extracted forward, And launch continue with with with and on our our own work in being conduct jurisdictions plan outside of and of Canada to in we the of reliance to products efficiencies to and towards on forms the we flexibility fees capabilities and overall it organization, over and strategic hand provides I'll operating States at with Riaz. levels impacts positive new increased numbers. the additional all United on realized dry and moving that, further turn cultivation back have
to companies. of many value you, our valuation cannabis Canadian more about relative nominal visible With enterprise is million, an Jenn. Thank $XX
the distinct goal, in to products this increase on three sales customers XX target only and shots at of we which product goal striking enthused they the in attributes new we We're versus to these Our categories year and our sales product a consumers product many about is in the offer February. have profile XX end entries, upwards. in With their driving XX aim prospect with fourth our categories for of expect products chord growth, the and quarters. third potential
inflection and opportune next point. QX will of are close our QX conference a our with an this your of not want the May, for we since coming for financial for you is attending call call. for QX end the conduct so year to this think inform but reports the together I report around end will at of I timing support Thank that So end and you August.
call. We attending don’t concludes now call. XXXX Thank year-end This on have today’s you any today’s conference presentation. analysts for Emerald's
disconnect. now may You
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.